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The possibility of an immunologic basis for the tissue injury associated with 
persistent lymphocytic choriomeningitis (LCM) 1 viral infection in mice is sug- 
gested by several pieces of evidence. First, chronic LCM infection per se usually 
is not associated with cytopathogenicity. Mice persistently infected with LCM 
(LCM carriers)  of most strains demonstrate high titers of virus in virtally all 
tissues and yet most of these tissues show little, if any, evidence of cellular in- 
jury (1-6). Also, LCM infection of a variety of cells in tissue culture is usually 
not accompanied by cell injury despite active viral replication (7-10). Second, 
adult mice inoculated with LCM virus develop an acute fatal disease only when 
they make an anti-LCM response. In such adult infections, immunosuppression, 
by several methods, prevents acute disease (11-15). 
The LCM carrier state develops in mice inoculated with LCM virus shortly 
after birth (5, 16, 17) or infected transplacentally in utero (18). Such chronically 
infected mice carry high titers of virus in blood and organs and apparently make 
an anti-LCM antibody response throughout their life (6, 19). LCM carrier mice 
of several strains develop an associated chronic disease. Those strains carrying 
the  largest amount  of LCM  virus  and  apparently making the  greatest  anti- 
LCM antibody response develop the earliest and most severe disease. 
* This is publication No. 360 from the Department  of Experimental Pathology, Scripps 
Clinic and  Research Foundation,  La Jolla, California. This  research was supported  by a 
United States Public Health Service Grant AI 07007, Atomic Energy Commission Contract 
AT (04-3)410 and United States Public Health Service  Training Grant GM683. 
Recipient of Career Development Award I KO4 AI 42580-01 AID from the United States 
Public Health Service. 
1 Abbreviations used in this paper: CNS, central nervous system; i.p., intraperitoneally; 
i.s., intraspinally; i.v., intravenously; LCM, lymphocytic choriomeningitis; LCM  carriers, 
mice persistently infected with LCM; PMN, polymorphonuclear leukocytes. 
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The present studies further define the role of the anti-LCM immune response 
in production of lesions in chronic LCM disease. Parabiosis of immune mice to 
isologous LCM carriers or transfer of immune lymphoid cells to isologous LCM 
carriers  initiated and/or intensified chronic disease  in the  carriers  of  several 
murine strains. In addition, the passive transfer of isologous or heterologous 
anti-LCM antibody to persistently infected carrier mice caused the prompt ap- 
pearance of acute necrotizing inflammatory lesions. This phenomenon seemed 
to result from the interaction of circulating anti-LCM antibody with antigen 
(virus  or  virus-induced) associated  with  cells.  The  acute  inflammation was 
replaced several days later by a  mononuclear infiltration reminiscent of that 
associated with classical delayed type hypersensitivities. 
Materials and Methods 
Host.-- 
Mice: Breeders for SWR/J, B10D2 old line and C3H inbred strains were obtained from 
Jackson Memorial Laboratories, Bar Harbor, Maine. NZB breederswere obtained from  Labo- 
ratory Animal Center, Medical Research Council, Carshalton, Surrey, England. Breeding was 
performed in our laboratories. 
Virus carrier state:  Newborn mice were inoculated within the first 15 hr of life with 1000 
X LDs0 doses of virus prepared from infected isologous mouse brain. Details of virus passage, 
inoculation procedure, development of the LCM carrier state and associated chronic disease 
have been previously reported (20). 
Immune state:  Animals immune to LCM virus were obtained by both natural and acquired 
infection. Babies neonatally infected with LCM excrete large amounts of virus, thereby nat- 
urally infecting their mothers who do not develop overt disease. At the time of weaning, the 
mothers  have good titers  of circulating complement-fixing anti-LCM  antibody.  Similarly, 
adult mice artificially infected with intraperitoneal (i.p.) injections of sublethal doses of virus 
prepared from infected isologous tissue develop complement-fixing  anti-LCM antibody. Adult 
male and female Hartley guinea pigs infected with i.p. and subcutaneous injections of virus 
demonstrated both anti-LCM-neutralizing and complement-fixing  antibodies. 
Virus.  -- 
Source:  Seed LCM virus used was mouse brain passage NIH strain CA 1371, lot 7022 pro- 
vided by Dr. Wallace Rowe of National Institute of Allergy and Infectious Disease, Bethesda, 
Md. Methods of handling and diluting virus for inoculation have been previously described 
(20). 
Titration: Virus titrations were carried out  by intracerebral  inoculation of serial 10-fold 
dilutions of virus into groups of 6-10 Swiss-Webster mice. Mice weighed 10-14 g and  LD~0 
titration end points were calculated by Reed and Muench method (21). 
Anti-LCM Antibody.-- 
Determinations:  Complement fixation and neutralizing tests for anti-LCM antibody have 
been previously reported  (19). LC~  complement-fixing antigen  was  kindly provided  by 
Dr. Hercules and Dr. Parker of Microbiological  Associates, Inc., Bethesda, Md. 
Parabiosis, Cell and Serum Transfer.-- 
Parablosls:  Parabiotic  union using coelomic attachment to obtain a common peritoneal 
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Combinations of parabionts used were: (a) immune to virus carrier, (b) immune to immune, 
(c) virus carrier to virus carrier, and (d) normal (LCM virgin) to virus carrier. 
Cdl transfer: Spleens from immune, normal, or virus carrier mice were minced and passed 
through a 100-mesh nylon filter. The cells were washed twice in cold medium 199 and viability 
was checked with trypan blue. Specific procedures used to obtain, prepare, count, and test for 
viability of cells have been previously reported (22, 23). Nonviable cell preparations were ob- 
tained by rapidly freezing and thawing three times and cell viability was tested to ensure that 
all of the cells were dead. Isologous  recipients were sacrificed at 4--6 hr, and 1, 3, 5, 7, and 14 
days after intravenous (i.v.)  injection of 7 X  108 viable or nonviable spleen cells. In several 
experiments, 7 X  l0  s viable spleen cells from immune donors were employed. 
Serum transfer: Sera collected from immune isologous and heterologous  donors were titered 
for anti-LCM antibody activity by complement fixation (mouse, guinea pig)  and neutraliza- 
tion (guinea pig) tests. High titered anti-LCM mouse sera (complement-fixing titers above 
1 : 256) or guinea pig anti-LCM sera (complement-fixing  titer greater than 1 : 256 and neutrali- 
zation titer 1 log or more protection) were pooled separately, passed through a 0.2/z Millipore 
filter and stored at -70°C until use. Pooled serum was injected i.v. or intraspinally (i.s.) (24). 
The i.v. schedule was injection of 0.2 ml serum i.v. and 0.25 ml i.p. at time 0, 12, 24, and 30 
hr. Animals were sacrificed  36 hr, 4, 7, and 14 days after the initial injection. Animals in- 
jected i.s. received 0.02 ml serum intrathecally via a high lumbar-low thoracic intravertebral 
space. A short bevel 26 gauge needle was used and animals were sacrificed 4-6 hr, 1, 3, and 7 
days after inoculation. 
Immunofluorescent and Histopathologic Techniques.-- 
fmmunofluorescence: Tissue blocks were  snap-frozen in liquid nitrogen and sections 4/z 
thick  were  cut,  fixed,  and examined by the  direct  immunofluorescent technique  (7,  25). 
Fluorescein-labeled rabbit anti-mouse ~,-globulin, anti-mouse albumin, anti-mouse C3  (third 
component of complement), anti-guinea pig C3 and anti-rat fibrinogen, plus guinea pig anti- 
LCM monospecific antisera were used. Details of the preparation of these reagents have been 
reported (25, 26). 
Histology: Formalin-fixed paraffin sections of tissue were stained by hematoxylin and eosin 
and periodic acid-Schiff (PAS) methods. In addition to single sections of lymph node, thymus, 
heart, lung, skeletal muscle, kidney, adrenal, spleen, pancreas, and omental fat, multiple sec- 
tions of liver and sections of lumbar, thoracic and cervical cord,  medulla, pons, cerebellum 
including fourth ventricle, mesencephalon, diencephalon, and cerebral cortex were studied. 
RESULTS 
Parabiosis  Between LCM Carriers and Isologous Partners Immunized Against 
LCM Virus.- 
Mortality in LCM carrier strains:  In certain routine strains a  spectrum,  ex- 
tending from focal tissue damage to death,  occurs after parabiotic union with 
more severe involvement occurring in the LC1V[ carrier parabiont (Table I). Of 
the 4  strains tested,  the SWR/J  strain was most susceptible wifll over 60%  of 
LCM  carrier parabionts dying at the end of the 1st wk and 77% dying by the 
end of the 2nd wk. The NZB and B10D2 old line had a LC1V[ carrier parabiont 
mortality of 40 %  at 2  wk,  while the C~H parabionts had no adverse changes 
during the 30 day observation period. 
Histopathologic manifestations:  Tissue injury occurred after the parabiosis of 
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line strains (Table I). The liver, kidney, and brain were the most severely in- 
jured tissues and, while both parabionts suffered, the LCM carrier was always 
more severely involved. The most  affected organ was  the liver where injury 
ranged from scattered foci to large confluent areas of necrosis with mixed in- 
flammatow infiltrates. The large confluent necrotic liver lesions occurred com- 
monly and early (by the 4th day) in SWR/J carriers but were infrequent at any 
time in NZB and B10D2 old line carriers (Fig. 1). These necrotic areas contained 
both plasma proteins and viral antigen and occurred in no particular anatomic 
distribution. In the kidney in SWR/J and NZB strains, there was an accelera- 
tion in the progression of tissue injury fron basement membrane thickening, 
usually seen in  carrier mice of this  age,  to intracapillary  hyalinization and, 
finally, capillary occlusion, while in the B10D2 old carrier parabiont, mesangial 
proliferation and basement membrane thickening were the predominant lesions. 
In  the  brain,  an  increased  incidence  of  lymphoid  proliferation and  mono- 
nuclear infiltrates in SWR/J,  NZB, and B10D2 old carriers were noted in the 
perivascular spaces and meninges. In contrast, no apparent tissue injury in any 
organ was seen in either the carrier or immune parabionts of the Call strain 
(Table I). 
Parabiosis Between LCM Carriers and Normal (LCM Virgin) Isologous Part- 
nets.- 
The  most striking change in these pairs was  the apparent trapping  of cir- 
culating antigen-antibody complexes in the glomeruli of the isologous normal 
parabiont. In three separate experiments using SWR/J inice the normal para- 
biont's right kidney was removed at time of parabiotic union, and the left kid- 
ney, 6 days later. Immunofluorescent study of the post parabiotic kidney re- 
vealed deposition of LCM antigen, 3,-globulin,  and C3 in the glomeruli along the 
basement membrane of capillaries and in the mesangia in a granular type pat- 
tern (Fig. 2), while the preparabiotic kidney as well as kidneys taken from nor- 
mal to normal or immune to immune parabionts did not reveal any significant 
deposits. 
Transfer of Spleen Cells from Immune Donors to Isologous LCM Carrier Re- 
cipients.- 
Production of tissue injury:  Spleen cells from SWR/J  immune donors were 
transferred  to  4-6-week  old  SWR/J  carriers.  Normal  SWR/.I  donors  and 
recipients served as controls and results from one of four such experiments are 
shown in Table II. 8 of 10 virus carrier recipients showed leptomeningeal and/or 
perivascular round cell infiltrations in the brain 14 days after transfer (Fig. 3), 
while in  contrast,  only 5  out  of 40  noninoculated virus  carrier litter mates 
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ground  of chronic disease lesions was not increased when normal or nonviable 
immune cells were given to SWR/J  carriers. 
The transfer of 7  X  10  s immune C3H spleen cells i.v. to C3H carriers did not 
cause any detectable injury in Call carrier recipients. 
TABLE I 
Parabiosis  of Immune to LCM Carrier Mice 
Parabionts 
Cumulative mortality (days)* 
7  14  30 
Necrotizing 
lesions 
(30 days survivors) 
SWR/J  VC-I*  11/18  14/18  14/18  4/4 
NZB  VC-I  0/8  3/8  3/8  5/5 
B 10D2 old  VC-I  0/8  3/8  3/8  5/5 
C3H  VC-I  0/12  0/12  0/12  0/12 
SWR/J  VC-VC  0/4  0/4  0/4  4/4§ 
SWR/J  I-I  0/4  0/4  0/4  0/4 
* Number of parabiotic pairs in which one partner died/total number of parabiotic pairs. 
Mice used were 2-3 months old. 
* VC, virus carrier; I, immune. 
§ Usual chronic disease lesions consisting of either mild renal glomerular  injury or focal liver 
necrosis with predominant round cell infiltration (6). 
TABLE II 
Intravenous  Transfer  of Isologous Immune Spleen  Cells to 4-6  Wk Old LCM Carrier  Mice 
Recipients 
Cells 
Number  Type 
nistopathologic CNS lesions* 
Lepto-  Pefivascular 
meningitis  round cell 
cuffing 
SWR/J carriers  7 )< l0  s  Immune  5/10,  8/10 
7 X  10 6  Immune freeze-thaw  0/5  1/5 
7 X  10 6  Normal  1/10  1/10 
--  --  2/40  5/40 
C3H  7 M l0  s  Immune  0/8  0/8 
* Animals sacrificed 14 days after i.v. cell transfer. 
* Number with lesions/total number of mice. 
Temporal  sequence  of  lesions:  24  SWR/J  4-6-wk  old  carriers  were  given 
7 X  106 isologous viable immune spleen cells i.v. and sacrificed 4-6 hr and 1, 3, 
5, 7, and 14 days later. The central nervous systems (CNS) of these mice were 
examined for appearance of lesions because of the low background of chronic 
disease lesions in this tissue (10-15 %). No lesions were detected until 7 or more 
days after transfer when perivascular round cell infiltrations occurred regularly 
in about 90 %  of recipients. When lesions occurred they were scattered with a 
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isologous viable immune spleen cells were injected into SWR/J carriers lesions 
did not occur until after the 7th day. 
Transfer of Immune Sera to LCM Carrier Mice.-- 
Effect  of  i.v.  transfer  of  immune  isologous  and  homologous  serum  to  LCM 
carrier recipients:  Virus carriers were injected with a  total of 1.8 ml of pooled 
immune serum over a  30 hr period and sacrificed 6 hr after the  last  injection. 
75 %  of  SWR/J carriers  receiving  serum  from SWR/J or C~H  immune  mice 
showed  acute  inflammatory  lesions  in  the  liver  and/or  brain,  while  no  C3H 
carriers  receiving  either  immune  serum  developed  lesions  (Table  III). Histo- 
TABLE III 
Intravenous Transfer of Immune Serum to 4-6-Wk Old LCM Carrier Mice* 
Recipients 
Histopathologic lesions~  Serum  (6 hr) 
Source  Type  Liver  Brain 
SWR/J carriers  SWR/J  Immune§  9/12[]  5/12 
C3H  Immune  4/6  2/6 
Guinea pig  Immune  4/6  3/6 
SWR/J  Normal  2/11  0/11 
--  --  4/40  0/40 
C3H carriers  C3H  Immune  0/10  0/10 
SWR/J  Immune  0/10  0/10 
Guinea pig  Immune  0/10  0/10 
Normal SWR/J  SWR/J  Immune  0/10  0/10 
Guinea pig  Immune  0/10  0/10 
* Transfer of 0.2 ml serum i.v. at time 0, 12, 24 and 30 hr. Injections  of 0.25 ml given i.p. 
at similar times. Animals sacrificed 6 hr after final injection. 
:~ Acute inflammatory lesions with predominant polymorphonuclear leukocyte infiltration. 
§ Pooled anti-LCM antibody showing high complement fixing (mouse, guinea pig) and/or 
neutralizing  (guinea pig) activity. 
]] Number with lesions/total  number of mice. 
pathologically,  scattered  areas  of  severe  focal  necrosis  with  a  predominant 
polymorphonuclear leukocyte (PMN)  infiltration occurred in the livers of virus 
carriers  of the  SWR/J  strain.  These  areas  were easily distinguished  from the 
usual  round  cell  infiltrations  of chronic disease.  In the  brain  a  similar  acute 
perivascular infiltration and leptomeningitis was seen (Fig. 4). Normal SWR/J 
recipients  injected  with  immune  serum  and  SWR/J  carriers  injected  with 
normal serum served as controls and did not show acute inflammatory lesions. 
When SWR/J carriers receiving immune serum were sacrificed 4 or more days 
after transfer,  lesions  contained  mostly mononuclear cell infiltrates  consisting 
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seen and comprised up to 2-4% of the cellular infiltrate. Some of the plasma 
cells contained Russell bodies. Eosinophils and polymorphonuclear leukocytes 
were rarely seen at this time. 
Effect of i.v. transfer of heterologous  serum:  SWR/J carriers receiving 1.8  ml 
of guinea pig anti-LCM  serum over a  30 hr period developed acute inflam- 
matory brain and liver lesions of varying severity 4-6 hr after final injection 
(Table III). Cellular infiltrate appeared identical to that occurring 4-6 hr after 
i.v. isologous or homologous immune serum transfer to SWR/J  carriers. Im- 
munofluorescent study of glomeruli showed deposits of guinea pig "y-globulin, 
presumably  anti-LCM  antibody.  Sections  were  stained  by  direct  immuno- 
fluorescent technique with fluoresceinated rabbit anti-guinea pig 7s "y-globulin 
that had been absorbed with mouse ~/-globulin  (Fig.  5). No immunoglobulin 
TABLE IV 
Intrasplnal Transfer of Immune Serum to 4-6-Wk Old SWR/J Carrier Mice 
Recipients  Number 
Serum  ttistopathologic lesions* 
Source  Type 
(Acute  (Round 
cell) 
7 da, 
SWR/J carriers  16  SWR/J  Immune  7/8,  8/8 
10  Guinea pig  Immune  5/5  5/5 
20  SWR/J  Normal  0/10  2/10 
Normal SWR/J  15  SWR/J  Immune  0/10  0/5 
15  Guinea pig  Immune  0/10  0/5 
* Histologic lesion 4-6 hr after intraspinal transfer of 0.02 ml anti-LCM antibody consists 
of a polymorphonuclear  infiltration in leptomeninges  and choroid plexus, especially  choroid 
plexus of the fourth ventricle. The lesion seen at 7 days after transfer is a predominantly 
mononuclear infiltration. 
:~ Number with lesions/total number of mice. 
deposits occurred after the injection of this heterologous antiserum into non- 
infected SWR/J mice nor with normal guinea pig serum inoculated into SWR/J 
carriers. 
Intraspinal transfer of isologous  anti-LCM serum to SWR/J  carriers:  SWR/J 
carriers  developed  an  acute  necrotizing polymorphonuclear response  in  the 
leptomeninges and  choroid plexus 4-6 hr  after i.s.  injection of only 0.02  ml 
isologous anti-LCM serum (Table IV, Fig. 6b). When sacrificed at 7 days these 
same areas had a predominantly lymphocytic infiltration with occasional plasma 
cells  (Figure 6c). These plasma  cells,  occasionally containing Russell  bodies, 
comprised up to 3-4 % of the total cellular infiltration. Animals sacrificed at 1 
or 3 days showed varying gradations of a mixed inflammatory response which 
consisted mainly of round cells at  the  3rd  day. The i.s.  inoculation  of heter- 
ologous guinea pig anti-LCM  serum  caused similar  histologic  lesions.  Early LYMPHOCYTIC  CHORIOMENINGITIS VIRAL  INFECTION.  II 
palymorphonuclear  response  was  not  observed  in  SWR/J  carrier  controls 
receiving normal mouse serum and normal SWR/J  recipients receiving LCM 
immune serum. 
DISCUSSION 
The most obvious lesions in several murine strains persistently infected with 
LCM  virus  are chronic glomerulonephritis, focal hepatic necrosis,  and  inter- 
stitial  lymphoid infiltrations in many of the body's tissues.  Less frequently, 
there is  a mild perivascular round cell infiltration in the CNS. We have pre- 
viously  demonstrated  that  the  glomerulonephritis  has  an  immune  complex 
pathogeneis (6). First, the virus calls forth a host anti-viral antibody response 
with the resultant formation of circulating infectious virus-antibody complexes. 
This can be shown by the immunologic precipitation of either host IgG or C3 
from the serum, which removes approximately 2 logs of titratable infectivity, 
while precipitation of albunfin, as a  control, has no such effect. The trapping 
and associated accumulation of virus, anti-viral antibody and C in the glomeruli 
leads  to  the  induction  of  glomerulonephritis.  Hence,  it  is  not  surprising  to 
demonstrate  either  deposition  of v-globulin  from  ~  guinea  pig  immunized 
against LCM virus in the glomeruli after heterologous serum transfer, or the 
deposition of "/-globulin (presumably anti-LCM antibody), viral antigen,  and 
C in the glomeruli of a normal mouse several days after parabiosis to an isolo- 
gous LCM carrier parabiont. 
The necrotizing lesions in the liver and elsewhere in carrier mice of certain 
strains are probably in part the result of an immunologic reaction with LCM 
antigen(s) in infected cells at the lesion site. Intravenous transfer of anti-LCM 
immune serum to LCM carrier mice results initially in acute necrotizing lesions 
predominantly  in  the  liver  and  brain.  Viral  antigen  can  be  located  in  the 
cytoplasm and  on  or  near  the  surface of  many infected cells,  i.e.,  hepatic 
parenchymal cells,  choroid cells in the brain, and in endothelial cells of blood 
vessels. Presumably, antibody meets the cell-associated antigen and combines 
with  it, polymorphonuclear leukocytes accumulate probably as a  result of C 
activation,  and acute inflammation ensues. The involvement of the C  system 
is suggested by preliminary experiments where the appearance of PMN's and 
ensuing  necrosis  was  inhibited  by decomplementing  SWR/J  carriers  at  the 
time  of serum  transfer3  In  addition,  in  vitro experiments have  shown  that 
anti-LCM  antibody and complement have a  rapid  cytotoxic effect on LCM- 
infected culture cells.  This cytotoxic effect is apparently closely dependent on 
the proportion of culture cells infected (27). 
Polymorphonuclear leukocytes present in the acute necrotizing lesion after 
an  anti-LCM  antibody transfer are  replaced  within  3  days by mononuclear 
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cells. This round cell infiltration appears similar to those infiltrations associated 
with  classic delayed hypersensitivities, consisting  predominantly of lympho- 
cytes and histiocytes with occasional plasma cells (28). In the CNS of SWR/J 
carriers,  this round cell infiltration is hardly distinguishable from the classic 
perivascular round cell infiltrations seen in allergic encephalomyelitis (25,  29) 
and differs from a fading Arthus reaction by its paucity of plasma cells (30). 
The recency of these mononuclear infiltrates after antibody transfer is suggested 
by the  presence of  cells of lymphoblastic series  as  well  as  lymphoidal  cells 
undergoing mitosis. If, as appears to be the case, serum antibody can induce 
mononuclear inflammatory lesions similar  or identical to  those in  presumed 
classical cellular hypersensitivity, it is extremely difficult to ascribe with cer- 
tainty any of the changes seen in this disease exclusively to cellular mechanisms 
(3). 
Other pathogenetic pathways besides the antibody-C-mediated system may 
also cause tissue injury in chronic LCM infection. Spleen cells from isologous 
immune  donors  injure LCM  infected tissue  culture  cells  in  the  absence  of 
added  C,  although  the  time needed to produce this  injury is  longer than is 
needed to produce comparable injury with serum antibody in the presence of 
C  (27). Similarly, the lesions developing in vivo after transfer of cells take a 
number of days, while those after transfer of antibody in the doses employed 
here, appear in a few hours. Whether the immune splenocytes elaborate humoral 
factors such as antibody and C, a cytotoxic substance, or cause injury by direct 
cell-cell interaction is not as yet clear. However, the  susceptibility of several 
C5-deficient strains  of mice both to lethal  effects of inoculation with LCM 
virus as adults and to ch onic disease associated with persisting LCM infection 
suggests either an alternative non-C-mediated pathway or a system in which 
C  components beyond activation of C3 are not prerequisites for tissue injury 
(31, 32). 
Although all mice infected at birth with LCM virus carry the virus in their 
blood and organs and make an anti-LCM antibody response throughout life, 
only certain of these strains develop associated chronic disease (6). Failure to 
appreciate this variation in strain susceptibility led to disagreement as to the 
presence  or  absence  of  chronic disease.  Volkert  (33),  who  did  not  observe 
disease in LCM carriers, worked with both C~H and AKR strains. In careful 
experiments  utilizing  isologous  anti-LCM  immune  cell  or  serum  transfer in 
C,H  carriers,  he was  not  able  to detect clinical illness  and did not look for 
histological injury (4,  34,  35).  We too have used parabiosis,  cell and  serum 
transfer and also have been unable to detect either clinical or histopathological 
injury in C,H carriers. Although the infected C3H mouse carries LCM virus in 
its  tissues  and makes  an anti-LCM  antibody response, it quantitatively has 
significantly less  (i.e., 2 logs) virus and apparently makes less anti-viral anti- 
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The importance of the quantitative aspects of viral infection in relationship to 
cellular damage or the appearance of clinical symptoms is not without prece- 
dent. The safety of attenuated live vaccines are to a great extent due to low 
levels  of  virus  production.  Furthermore,  in  studies  of  naturally  or  experi- 
mentally  occurring  infections  such  as  inapparent  neurotropic  arbor  virus 
infections, lack of clinical or pathological disease is not associated with failure 
of viral invasion or replication, but rather with the number of cells  infected. 
Although infectious arbor virus can be found in both apparent and nonapparent 
infections,  neither  clinical  symptoms  nor  histologic  evidence of  encephalitis 
occur until virus titer reaches approximately 105 LDs0 per 0.03 g of brain (36). 
The tissue injury associated with persistent LCM infection is best seen in 
mice of strains such as  SWR/J  which carry large amounts of virus. Hotchin 
(3,  37),  who first described in part chronic LCM disease,  worked with  Swiss 
Albino herd-bred strain  (NYLAR-A) which is probably closely related to the 
inbred Swiss Albino SWR/J strain we have employed. However, Hotchin was 
not  able to induce tissue injury in NYLAR-A carriers after the  injection of 
immune anti-LCM serum from mice, rabbits, or monkeys, or after transfer of 
viable immune  spleen cells,  although he did report induction of a  disease in 
carriers after parabiotic union to immune mice  (38). His inability to induce 
disease in carrier mice with either anti-LCM antibody or immune cells, plus his 
failure to detect anti-LCM  antibody led him to postulate an "autoimmune" 
basis for the chronic disease (3, 16, 38). From the present studies it seems much 
more likely that  the  chronic disease  is  the  result  of  an  anti-LCM  immune 
response interacting with the virus. Hotchin's failure to induce tissue injury in 
carrier mice after the injection of anti-LCM serum may be related to the virus 
or mouse strain employed or to the time and method of assessing  injury. Failure 
to detect an  effect of transferred cells  between  incompletely inbred  animals 
could also reflect rejection of the transferred cells on the basis of histoincom- 
patibility. 4-8 wk after parabiosis between carrier and immune mice, Hotchin 
noted the occurrence of a clinical runting syndrome (ruffled hair, wasting, and 
anemia)  (38). Histologic studies  of liver and spleen sections from parabionts 
did not reveal any significant findings. The description presented by Hotchin 
might possibly have been the result of histoincompatibility but the differences 
in patterns of injury noted in this report and in Hotchin's could also be due to 
different mouse or virus strains used. 
Some of the major characteristics of chronic LCM disease may be found in 
other chronic viral infections. Thus in Aleutian disease of mink (39,  40)  and 
lactic dehydrogenase virus irtfection of mice (6, 41, 42) chronic viral infection, 
viremia, circulating virus-gamma globulin complexes, and deposition of these 
complexes in the glomeruli occur. In visna (43) there also is persistence both of 
circulating virus and anti-viral antibody. It is of interest that in Aleutian disease 
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viral titers. It is  only after 2-3 wk of infection, with the appearance of host 
immune response to viral antigen(s), that tissue injury occurs (44). 
The presence  of  anti-viral  antibody  is  associated  with  recovery from  or 
immunity to many virus infections. But such antibody may not be universally 
beneficial, since tissue damage in many acute viral diseases occurs at the end 
of the viremia stage when antibodies are first appearing. It seems possible that 
the interaction of antibody and virus may precipitate or contribute to tissue 
damage  caused  by  virus  replication.  In  addition,  genetically  determined 
predispositions controlling viral multiplication and/or degree and type of host 
immune response may influence the severity and perhaps nature of the disease. 
Although all evidence to date suggests that viral antigen and anti-viral antibody 
is  involved in chronic LCM  disease,  the possibility must be considered that 
new (neo) antigen coded for by the virus also may be involved. 
SUMMARY 
Tissue injury (chronic disease)  associated with persistent LCM infection is 
apparently  caused  by  the  host  immune  response  to  the  virus.  Employing 
parabiosis or cell transfer from hyperimmune donors to isologous virus carriers, 
the tissue injury of chronic disease could be initiated and/or intensified. Fur- 
thermore, the  transfer of  anti-LCM  antibody to SWR/J carrier mice results 
in acute necrotizing inflammatory lesions in regions of viral persistence, followed 
by chronic mononuclear infiltrates quite similar to those seen after the transfer 
of immune cells. 
The pathogenesis of the nonglomerular tissue injury of chronic LCM disease 
is apparently at least in part related to the interaction of circulating anti-LCM 
antibody with viral antigen at the tissue site.  Trapping of circulating virus- 
antibody complexes in the glomerular filter is apparently the major cause of 
the glomerulonephritis. 
The authors wish to thank Dr. Karl Habel for his advice throughout and for his technical 
aid in performing intraspinal inoculation, A. Tishon and G. Sandford for technical assistance, 
and Phyllis Keim for preparation of this manuscript. 
BIBLIOGRAPHY 
1.  Traub, E. 1936. The epidemiology of lymphocytic choriomeningitis in white mice. 
J. Exp. Med. 64:183. 
2. Traub,  E.  1936. Persistence  of lymphocytic choriomeningitis  virus in immune 
animals and its relation to immunity. J. Exp. Med. 63:847. 
3.  Hotchin, J.  1962. The biology of lymphocytic choriomeningitis  infection:  virus- 
induced autoimmune disease. Cold Spring  Harbor Syrup. Quant. Biol. 27:479. 
4.  Volkert,  M., and J. H. Larsen.  1965. Immunologkcal tolerance  to viruses.  Progr. 
Med. Virol. 7:160. 
5. Volkert,  M.,  and  L.  tlannover.  1964. Studies  on  immunological  tolerance  to 
LCM virus. 3. Duration and maximal effect of adoptive immunization of virus 
carriers. Acta PathoI. Microbiol. Scan& 60:577. 12  LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION. II 
6.  Oldstone, M. B. A., and F. J. Dixon.  1969. Pathogenesis of chronic disease asso- 
ciated with persistent lymphocytic choriomeningitis viral infection.  I.  Rela- 
tionship  of  antibody production  to  disease in  neonatally  infected  mice.  J. 
Exp. Med. 19.9:483. 
7.  Oldstone, M. B. A., and F. J. Dixon.  1968. Direct immunofluorescent tissue cul- 
ture assay for lymphocytic choriomeningitis virus. J. Immunol.  100:1135. 
8.  Wilsnack, R.  E., and W. P. Rowe.  1964. Immunofluorescent studies on  the his- 
topathogenesis of lymphocytic choriomeningitis virus infection. J.  Exp.  Mecl. 
120:829. 
9.  Petersen, I. R., and M. Volkert. 1966. Multiplication of lymphocytic choriomen- 
ingitis virus in suspension cultures of Earle's strain L cells. Acta. Pathol.  Micro- 
biol. Scand.  67:523. 
10.  Brenda, R., and J.  Cinatl.  1962.  Multiplication of lymphocytic choriomeningitis 
virus in bottle cell cultures.  Experimental data for the preparation of highly 
infectious fluids. Acta.  Virol.  5:164. 
11.  Rowe, W. 1956.  Protective effects of pre-irradiation on lymphocytic choriomen- 
ingitis infection in mice. Proc.  Soc. Exp. Biol. Med. 92:194. 
12.  Haas, V. H., and S. E. Stewart. 1956. Sparing effect of a methopterin and guana- 
zolo in mice infected with virus of lymphocytic choriomeningitis. Virology.  9.: 
511. 
13.  Hotchin, J., and H. Weigand. 1961. The effects of pre-treatment with x-rays on the 
pathogenesis of lymphocytic choriomeningitis in mice. I. Host survival, virus 
multiplication and leucocytosis. J.  Immunol.  87:675. 
14.  East, J., D. Parrott, and J. Seamer. 1964. The ability of mice thymectomized at 
birth  to  survive infection with lymphocytic choriomeningitis virus.  Virology. 
29.:160. 
15.  Hirsch, M., F. Murphy, H. Russe, and M. Hicklin. 1967. Effects of antithymocyte 
serum on lymphocytic choriomeningitis (LCM)  virus infection in mice. Proc. 
Soc.  Exp.  Biol.  Med.  125:980. 
16.  Hotchin,  J.,  and  M.  Cinits.  1958. Lymphocytic  choriomeningitis infection  of 
mice as a  model for the study of latent virus infection. Can.  J.  Microbiol.  4: 
149. 
17.  Traub,  E.  1960. Uber  die  immunologioche  toleranz  bei  der  lymphocytiiren 
Choriomeningitis der M~use. Zentrabl.  Bakteriol.  Parasitenk. Infektionskr.  ttyg. 
Abt. Orig. 177:472. 
18.  Traub,  E.  1939. Epidemiology of the lymphocytic choriomeningitis in a  mouse 
stock observed for four years. J. Exp. Med. 69:801. 
19.  Oldstone, M., and F. J. Dixon. 1967. Lymphocytic choriomeningitis: production of 
antibody by "tolerant" infected mice. Science  (Washington).  158:1193. 
20.  Oldstone,  M.,  and  F.  Dixon.  1968. Susceptibility of different mouse  strains  to 
lymphocytic choriomeningitis virus. J. Immunol.  100:355. 
21.  Reed,  L.,  and H.  Muench.  1938. A  simple  method  of  estimating  fifty percent 
endpoints. Amer. J. ttyg. 27:493. 
22.  Harris, S., T. M. Harris, and M. G. Farber. 1954. Studies on the transfer of lymph 
node cells. I.  Appearance of antibody in recipient of cells from donor rabbits 
injected with  antigen. J.  Immunol.  72:148. MICHAEL  B.  A.  OLDSTONE  AND  FRANK  J.  DIXON  13 
23.  Roberts, J. C., Jr., and F. J.  Dixon. 1955. The transfer of lymph node cells in the 
study of the immune response to foreign proteins. J. Exp. Med.  109.:379. 
24.  Habel,  K.,  and  C.  P.  Li.  1951. Intraspinal  inoculation of mice in experimental 
poliomyelitis. Proc.  Soc. Exp. Biol. ]Fled. 78:233. 
25.  Oldstone, M. B. A., and F. J. Dixon. 1968. Immunohistochemical study of allergic 
encephalomyelitis.  Amer. J.  Pathol.  59.:251. 
26.  Unanue, E., and F. Dixon. 1964. Experimental glomerulonephritis. IV. Participa- 
tion of complement in nephrotoxic nephritis. J. Exp. Med. 119:965. 
27.  Oldstone, M. B. A., K. Habel, and F. J. Dixon. 1969. The pathogenesis of cellular 
injury associated with persistent LCM viral infection. Fed. Proc. 9.8:429 (abstr. 
969). 
28.  Waksman, B. H.  1959. A comparative histopathological study of delayed hyper- 
sensitive reactions. Ciba Found. Syrup.  Cellular Aspects oJ Immunity,  280. 
29.  Waksman, B. H., and R. D. Adams.  1962. A histologic study of the early lesion 
in experimental allergic  encephalomyelitis in the guinea pig and rabbit.  Amer. 
J. Pathol. 41:135. 
30.  Gell, P. G., and I. Hinde. 1954. Observations on the histology of the Arthus reac- 
tion and its relation to other known types of skin hypersensitivities.  Int. Arch. 
Allergy  A ppl. Immunol. 5:23. 
31.  Cochrane, C. G., and P. A. Ward. 1965. The role of complement in lesions  induced 
by immunologic reactions. Immunopathol. Int.  Syrup.  4th:433. 
32.  Polley,  M.  J.,  and H.  J.  Mfiller-Eberhard.  1967. Chemistry  and mechanism of 
action  of complement.  Progr.  Ilematol.  5:2. 
33.  Volkert,  M.  1964. Studies  on immunological tolerance  to LCM virus.  Perspect. 
Virol. 4:269. 
34.  Volkert,  M.  1963. Studies  on immunological tolerance  to LCM virus.  2. Treat- 
ment of virus carrier mice by adaptive immunization. Acta Pathol.  Microbiol. 
Scand.  57:465. 
35.  Volkert, M., and J. H. Larsen.  1965. Studies on immunological tolerance to LCM 
virus. 6. Immunity conferred on tolerant mice by immune serum and by grafts 
of homologous lymphoid cells. Acta. Pathol.  Microbiol.  Scand. 63:172. 
36.  Albrecht,  P.  1968.  Pathogenesis  of neurotropic  arbor  virus  infections.  Current 
Topics in Microbiol.  and Immunol. 43:45. 
37.  Baker,  F.,  and  J.  Hotchin.  1967. Slow  virus  kidney  disease  of mice.  Science 
(Washington). 158:502. 
38.  Hotchin, J.  1965.  Chronic disease  following lymphocytic choriomeningitis virus 
inoculation  and  possible  mechanisms  of  slow  virus  pathogenesis.  In:  Slow, 
Latent  and  Temperate  Virus  Infections.  National  Institute  of Neurological 
Diseases and Blindness. Monogr., No. 2, U. S. Public Health Service Publica- 
tion 1378:341. 
39.  Porter, D., and A. Larsen. 1967. Infectious virus-antibody complexes in the serum. 
Proc. Soc. Exp. Biol. IVied. 126:680. 
40.  Porter, D., A. Larsen, and H. Porter.  1969. The pathogenesis of Aleutian disease 
of mink.  I. In vivo viral replication and  the host antibody response  to viral 
antigen. J. Exp. Med. 130:575. 14  LYMPHOCYTIC  CHORIOMENINGITIS VIRAL  INFECTION.  II 
41.  Notkins, A., S. Mahar, C. Scheele, andJ. Goffman. 1966. Infectious virus-antibody 
complex in the blood of chronically infected mice. ]. Exp. Med. 124:81. 
42.  Notkins,  A. 1965. Lactic dehydrogenase virus. Bacteriol. Rev. 29:143. 
43.  Gudnad6ttir,  M.,  and P. P~lsson. 1965. Host-virus  interaction  in visna infected 
sheep.  J.  Immunol.  96:1116. 
44.  Porter,  D.,  and A. Larsen.  1968. Virus-host  interactions  in  Aleutian  disease of 
mink. Perspect. Virol. 6:173. FIG.  1.  Light photomicrographs of liver tissue from 2-3-month old LCM  carrier 
parabiosed to an immune isologous partner. Sections stained with hematoxylin and 
eosin. (a)  Scattered foci of necrosis  (arrows)  in a BIOD2 old LCM carrier sacrificed  7 
days after parabiotic union. Location of areas of necrosis  have no apparent relation- 
ship to hepatic architecture. (b) Higher power photomicrograph of a large confluent 
area of necrosis at left in an SWR/J LCM carrier sacrificed 4 days after parabiosis. 
15 FIG. 2.  Renal  glomeruli from an 8-wk o!d  SWR/J  normal (LCM  virgin) mouse 
stained with fluorescein-conjugated  rabbit antiserum to mouse 7S'g-globulin.  (a)  Kid- 
ney removed at  time of  parabiotic union to an SWR/J LCM  carrier. There  is  no 
detectable -g-globulin observed. Surrounding tubules are indicated by natural auto- 
fluorescence  brought out by overexposure.  (b)  Remaining kidney removed  after  6 
days parabiosis.  Mouse 3,-globulin can be  seen outlining the glomerular  basement 
membranes of capillaries in peripheral areas as well as being deposited in mesangia. 
FIG. 3.  Light photomicrograph of a  hematoxylin and eosin stained brain section 
from a 6-wk old SWR/J LCM carrier mouse 14 days after transfer of 7 )< 10  8  isologous 
immune spleen cells intravenously. Predominant round cell perivascular infiltration is 
seen in the pons. 
16 FIG. 4.  Light photomicrographs of hematoxylin and eosin stained tissues from a 
6-wk old SWR/J LCM carrier mouse 6 hr after last intravenous and intraperitoneal 
injection of high fiter isologous  antisera to LCM virus. Mixed cell infiltration with 
large numbers of polymorphonuclear cells are seen in: (a)  leptomeninges of cerebral 
cortex,  (b) liver. Normal SWR/J recipients injected with immune sera and carriers 
with normal sera served as controls and did not show similar lesions. 
17 FIG. 5.  Renal glomerulus from  a  6-wk old SWR/J LCM carrier receiving guinea 
pig antiserum to LCM virus. The preparation was stained with fluorescein-conjugated 
rabbit antiserum  to  guinea pig  7S  T-globulin that  had  been  absorbed with  mouse 
T-globulin.  Guinea pig T-globulin, presumably  antibody  to  LCM  virus,  is heavily 
deposited in  mesangial areas and  less on peripheral walls of glomerular capillaries. 
18 FIG. 6.  Fourth ventricle choroid plexus from 6-wk old SWR/J carrier mice receiving 
isologous anti-LCM serum intrathecally via a  high lumbar-low thoracic inoculation. 
(a)  Preparation stained with  fluorescein-conjugated guinea pig antiserum  to  LCM 
virus in an LCM carrier litter mate control not receiving serum. LCM viral antigen 
is seen in choroid cells and in endothelial cells of capillaries. (b) Light photomicrograph 
6 hr after intrathecal serum transfer. Acute necrotizing polymorphonuclear response is 
evident.  (c)  Light photomicrograph 7  days after intrathecal injection showing pre- 
dominant lymphocytic infiltrate. Occasional plasma cells and  a  large lymphoid cell 
undergoing mitosis (arrows) are seen in the infiltrate 
19 